Literature DB >> 15533326

A bi-directional mu-opioid-opioid connection between the nucleus of the accumbens shell and the central nucleus of the amygdala in the rat.

Eun-Mee Kim1, Joseph G Quinn, Allen S Levine, Eugene O'Hare.   

Abstract

The central nucleus of the amygdala (CeA) and the nucleus of the accumbens shell (NAc) have been shown to be involved in opioid-mediated feeding behavior. The present study examined whether mu-opioid signalling between the CeA and NAc affected feeding. Male Sprague-Dawley rats were fitted with one cannula placed in the CeA and two cannulae placed in the NAc, which allowed for coadministration of the mu-opioid receptor agonist [D-Ala(2), NMe-Phe(4), Gly-ol(5)]-enkephalin (DAMGO) in one site and the opioid antagonist naltrexone (NTX) in the other site. Single injection of DAMGO (2.4 nmol) into the CeA and bilateral injections of DAMGO (2.4 nmol) into the NAc stimulated feeding (P<0.05). The DAMGO-induced increase of food intake following injection into the CeA was decreased by bilateral injection of NTX (13.2 and 26.5 nmol) into the NAc at 2- and 4-h postinjections (P<0.05). In the reverse situation, the DAMGO-induced increase of food intake following injection into the NAc was decreased by injection of NTX (13.2 and 26.5 nmol) into the CeA at 1-, 2-, and 4-h postinjections (P<0.05). These results suggest that a bi-directional mu-opioid-opioid signalling pathway exists between the CeA and the NAc, which influences feeding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533326     DOI: 10.1016/j.brainres.2004.10.001

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Enterostatin inhibition of dietary fat intake is modulated through the melanocortin system.

Authors:  Ling Lin; Miejung Park; David A York
Journal:  Peptides       Date:  2006-11-17       Impact factor: 3.750

2.  Activating mu-opioid receptors in the lateral parabrachial nucleus increases c-Fos expression in forebrain areas associated with caloric regulation, reward and cognition.

Authors:  M Denbleyker; D M Nicklous; P J Wagner; H G Ward; K J Simansky
Journal:  Neuroscience       Date:  2009-05-05       Impact factor: 3.590

3.  Amylin receptor signaling in the nucleus accumbens negatively modulates μ-opioid-driven feeding.

Authors:  Sarah K Baisley; Brian A Baldo
Journal:  Neuropsychopharmacology       Date:  2014-06-24       Impact factor: 7.853

Review 4.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

5.  Which cue to 'want'? Opioid stimulation of central amygdala makes goal-trackers show stronger goal-tracking, just as sign-trackers show stronger sign-tracking.

Authors:  Alexandra G DiFeliceantonio; Kent C Berridge
Journal:  Behav Brain Res       Date:  2012-02-25       Impact factor: 3.332

Review 6.  Ventral pallidum roles in reward and motivation.

Authors:  Kyle S Smith; Amy J Tindell; J Wayne Aldridge; Kent C Berridge
Journal:  Behav Brain Res       Date:  2008-10-08       Impact factor: 3.332

7.  Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered 'wanting' for reward: entire core and medial shell mapped as substrates for PIT enhancement.

Authors:  Susana Peciña; Kent C Berridge
Journal:  Eur J Neurosci       Date:  2013-03-17       Impact factor: 3.386

Review 8.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

9.  Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: Possible mechanism underlying their behavioral effects.

Authors:  Olga Karatayev; Jessica R Barson; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Peptides       Date:  2009-09-24       Impact factor: 3.750

10.  Which cue to "want?" Central amygdala opioid activation enhances and focuses incentive salience on a prepotent reward cue.

Authors:  Stephen V Mahler; Kent C Berridge
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.